Why Farbe Firma is the Top Manufacturer of Noradrenaline (Norepinephrine) Injection
- Maulik Sudani
- Jul 2
- 9 min read
Last Updated: July 2, 2026
TL;DR: Noradrenaline (Norepinephrine) Injection - a sterile concentrated solution of norepinephrine, a catecholamine that acts as a potent alpha- and beta-1-adrenergic agonist (vasopressor), supplied commonly as a 1 mg/mL sterile concentrate (as norepinephrine bitartrate) in a glass ampoule for dilution and slow intravenous infusion through a central line - is the first-line vasopressor clinicians use to restore blood pressure in septic and other vasodilatory shock. Because a catecholamine in solution is exquisitely sensitive to oxidation, each ampoule must deliver a sterile, correctly concentrated, colourless solution, with the assay and catecholamine-degradation impurities, solution pH, the antioxidant and nitrogen-protection system, colour and clarity, particulate and endotoxin, a validated oxygen-excluded sterilisation route and verified container-closure integrity all mattering to potency and safety. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Noradrenaline (Norepinephrine) Injection at our Gujarat, India facility and supplies it to critical-care, emergency, anaesthesia and hospital-pharmacy services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Vasopressor catecholamine (alpha- and beta-1-adrenergic agonist) - norepinephrine, given by slow intravenous infusion, raises systemic vascular resistance and blood pressure and is the first-line vasopressor in septic shock, and Noradrenaline (Norepinephrine) Injection (a 1 mg/mL sterile concentrate as the bitartrate, diluted before central-line infusion) demands an accurately concentrated, colourless, oxidation-free solution in every ampoule.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, nitrogen-blanketed compounding and filling with a sodium-metabisulfite antioxidant and low-oxygen headspace, control of assay and catecholamine-degradation impurities by HPLC, solution pH, colour and clarity, particulate and endotoxin, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, forced-degradation and oxidation data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile catecholamine ampoule and ready-to-use infusion contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Noradrenaline (Norepinephrine) Injection Demands a Premium Manufacturer
Noradrenaline (Norepinephrine) Injection occupies a central, often life-sustaining place in critical care across every market. It is the drug a clinician reaches for when blood pressure collapses - in septic shock, where international sepsis guidance names it the first-line vasopressor; in other forms of vasodilatory or distributive shock; and as blood-pressure support in cardiogenic shock and during anaesthesia-related hypotension. Norepinephrine is the body's own principal sympathetic neurotransmitter, and as a medicine it is a potent agonist at alpha-1 receptors, driving vasoconstriction that raises systemic vascular resistance and blood pressure, with modest beta-1 inotropic support. What makes the product distinctive is chemical fragility rather than molecular complexity: norepinephrine is a catecholamine, and its catechol ring oxidises readily in air and light to coloured quinone and adrenochrome-type degradation products, so a solution that should be water-clear turns pink and then brown as it degrades and loses potency. Because the drug is infused directly into a vein - usually a central vein, titrated minute by minute against the blood pressure, often over many hours - every ampoule must be sterile, accurately concentrated and, above all, chemically intact and colourless, since the prescriber depends on a predictable, full-strength dose of a very potent, fast-acting vasopressor.
That clinical reality places exceptional demands on the manufacturer. Noradrenaline (Norepinephrine) Injection is presented as a sterile concentrate - for example 1 mg of norepinephrine base per mL, as 2 mg of norepinephrine bitartrate, in a 1 mL, 2 mL, 4 mL or 10 mL glass ampoule - that is diluted in an infusion fluid and given by controlled intravenous infusion, so the concentration must be exact and the fill accurate, because a potency error in a titrated vasopressor is a patient-safety event. The defining quality challenge is oxidative stability: the catechol group is readily oxidised, so the formulation is buffered to an acidic pH, roughly 3 to 4.5, where the catecholamine is most stable, an antioxidant such as sodium metabisulfite is added, the solution and its headspace are protected under nitrogen, and light protection is applied - all to keep the solution colourless and the assay on label across shelf life. The manufacturer must then reconcile two competing needs: the ampoule is usually terminally moist-heat sterilised, yet heat accelerates catecholamine oxidation, so the formulation, the oxygen-exclusion strategy and the sterilisation cycle have to be co-designed so the product survives sterilisation without discolouring or losing potency. Assay and the catecholamine-degradation impurities must be controlled by validated HPLC, colour and clarity checked against strict limits, sub-visible particulate held low, endotoxin very low and container-closure integrity assured. The label must carry the dilute-before-use instruction, the central-line administration and extravasation-necrosis caution, and the discard-if-discoloured warning. Choosing a Noradrenaline (Norepinephrine) Injection manufacturer that treats oxidation control, colour stability and the co-design of antioxidant protection with sterilisation as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Noradrenaline (Norepinephrine) Injection Manufacturer Apart
A world-class manufacturer of Noradrenaline (Norepinephrine) Injection invests in three areas that weaker suppliers underfund: precise, validated control of oxidation and colour - the antioxidant, nitrogen and pH system together with the catecholamine-degradation impurity profile by HPLC - which a catechol drug absolutely demands; a robust terminal-sterilisation, or where required fully aseptic, process co-designed with oxygen exclusion so a heat- and oxygen-sensitive solution survives without discolouring; and tender-ready dossier support, including the photostability, forced-degradation and oxidation data, for a high-alert critical-care vasopressor procured through hospital-pharmacy and ministry-of-health channels. It starts with the raw materials - pharmacopoeial norepinephrine bitartrate of controlled purity and low pre-existing degradation, the sodium-metabisulfite antioxidant, the pH-adjusting acid and buffer and sodium chloride for tonicity, each sourced from qualified, audited suppliers with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production. Because the entire safety and potency of the product depend on keeping the catecholamine unoxidised, the oxidation and colour data are treated as central evidence rather than supporting annexes, and the oxidative quality of the drug substance is guarded from the first receipt of raw material.
Compounding and filling then have to build - and defend - a colourless, full-strength solution. The batch is compounded in water for injection that has been de-aerated and blanketed with nitrogen, the antioxidant dissolved, the pH adjusted into the stable acidic window, and the whole operation carried out under a nitrogen atmosphere to exclude oxygen. The solution is filtered and filled into amber or light-protected glass ampoules under ISO Class 5 conditions with a nitrogen headspace, the ampoules sealed and, where the presentation allows, terminally sterilised by a validated moist-heat cycle locked into the master batch record - or, where heat cannot be tolerated, filled by a fully aseptic route. Filled units are 100 % inspected for fill, seal, colour and particulate; in-process and release testing confirm the norepinephrine assay and the concentration, the catecholamine-degradation impurities including the coloured oxidation products by HPLC, solution pH, colour and clarity against defined limits, the antioxidant content, visible and sub-visible particulate matter, and that endotoxin is held well within limits so the solution is safe for intravenous infusion. Because the product is a heat-stressed catecholamine whose safety hinges on remaining unoxidised, the assay, the impurities, the colour and the pH are confirmed together, before and after sterilisation, so the solution that leaves the plant is the same water-clear, full-strength solution the pharmacopoeia specifies - colourless, correctly concentrated and free of the pink-to-brown oxidation that signals a failed ampoule.
Quality Systems Behind Every Noradrenaline (Norepinephrine) Injection
Every Farbe Firma Noradrenaline (Norepinephrine) Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of norepinephrine against reference standards, control of catecholamine-related and oxidation impurities, solution pH, colour and clarity of solution against defined limits, antioxidant content, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule. Certificates of analysis are issued with full traceability back to each norepinephrine lot, the primary-packaging lot and the qualified person responsible for release. Because the product is terminally sterilised where the presentation allows and is inherently oxidation-prone, the assay, the impurities and the colour are qualified both before and after the sterilisation cycle so the catecholamine's stability to heat and oxygen is demonstrated rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, de-aeration and nitrogen-purging systems, validated terminal-sterilisation and filling equipment with nitrogen blanketing and 100 % inspection, light-protected compounding, holding and packaging, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because norepinephrine is a high-alert, potent vasopressor given directly into the bloodstream and its potency and safety are governed by oxidative stability and concentration accuracy, we treat the assay, the catecholamine-degradation impurities, the colour, the pH and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated conditions and ICH Q1B photostability, with the assay, impurities and colour followed across the study, so the solution stays colourless, full-strength and within specification across the labelled shelf life - and the protect-from-light and discard-if-discoloured storage instructions are supported by real data.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Noradrenaline (Norepinephrine) Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad critical-care and emergency-medicine portfolio. For Noradrenaline (Norepinephrine) Injection specifically, we supply the catecholamine vasopressor as a 1 mg/mL sterile concentrate, expressed as norepinephrine base and formulated as the bitartrate, in a range of ampoule fill volumes, together with ready-to-use dilute infusion presentations where required, under WHO-GMP conditions, with country-specific strengths, fill volumes, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the oxidation, photostability, forced-degradation, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Noradrenaline (Norepinephrine) Injection can request the colour-stability and accelerated- and photo-stability summaries up front, which is often the deciding technical evidence for an injectable catecholamine in hospital-formulary and ministry-of-health review, since it is precisely oxidative and colour stability that separate a full-strength vasopressor from a degraded one.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, forced-degradation and oxidation packages, sterilisation and container-closure reports, translated package inserts and artwork - including the dilute-before-use and intravenous-infusion administration instructions, the store-below-25-degrees-C, protect-from-light and discard-if-discoloured storage directions, and the central-line administration and extravasation-necrosis cautions of the class - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Noradrenaline (Norepinephrine) Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the nitrogen-protected compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through norepinephrine sourcing and pre-existing-degradation control, the design of an acidic, antioxidant-protected, nitrogen-blanketed catecholamine solution, the co-design of oxygen exclusion with terminal sterilisation, colour and impurity control by HPLC, photostability, fill and concentration accuracy for a potent titrated vasopressor, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a high-alert catecholamine vasopressor where oxidative stability, colour and concentration accuracy directly govern patient safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Noradrenaline (Norepinephrine) Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Noradrenaline (Norepinephrine) Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, nitrogen-blanketed compounding and filling with antioxidant protection and a low-oxygen headspace, validated terminal sterilisation where the presentation allows, 100 % inspection and continuous environmental monitoring.
Which strengths and presentations of Noradrenaline (Norepinephrine) Injection do you supply?
Our catecholamine vasopressor is available as a 1 mg/mL sterile concentrate - expressed as norepinephrine base and formulated as 2 mg/mL of norepinephrine bitartrate - in 1 mL, 2 mL, 4 mL and 10 mL glass ampoules, together with ready-to-use dilute infusion presentations where required. Custom fill volumes, container formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Noradrenaline (Norepinephrine) Injection mainly used for?
Noradrenaline (Norepinephrine) Injection is used as the first-line vasopressor to restore blood pressure in septic and other vasodilatory shock, and in other acute hypotensive states. It is given by slow intravenous infusion after dilution, titrated against the blood pressure and preferably through a central line; Farbe Firma verifies the norepinephrine assay, the catecholamine-degradation impurities, solution pH, colour and clarity, particulate matter and endotoxin at release so each ampoule delivers a colourless, full-strength solution. Dilute-before-use, central-line administration, extravasation-necrosis and discard-if-discoloured cautions are carried on the label.
Can Farbe Firma support country-specific registrations for Noradrenaline (Norepinephrine) Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, oxidation and forced-degradation packages, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Noradrenaline (Norepinephrine) Injection contract manufacturing?
MOQs vary by strength, fill volume, ampoule versus ready-to-use presentation, label complexity and dossier requirements. For our critical-care ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments